Our expert eye
Take a look at the experts and opinions that make Kindeva the leading CDMO in the industry.
Learn moreEvents
Whether leading, attending, or hosting, we stay busy and in the loop.
News
Whether making headlines for our work—or creating info you need now—you can find it here.
Kindeva Drug Delivery Announces Knowledge Transfer Partnership with Loughborough University to Study Sustainable Propellants
Kindeva Appoints Greg Sargen to Board of Directors
Kindeva Drug Delivery and Cambridge Healthcare Innovations Limited to Collaborate on Development of Novel Dry-Powder Inhaler Product
Kindeva seals deal to expand operations at Charnwood Campus
Viatris Inc. and Kindeva Drug Delivery Announce FDA Tentative Approval of the First Abbreviated New Drug Application Generic Version of Symbicort® (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol
Kindeva Appoints Shawn Cavanagh to Board of Directors
Kindeva and BOL Pharma Sign Agreement for Development of Inhaled Cannabinoid Products
Kindeva Drug Delivery Celebrates Breaking Ground for New Headquarters
Q&A with Kindeva Drug Delivery: Putting patients at the centre of drug development
Planning for Brexit : A case study on the strategic role CDMOs can play for their customers
Kindeva experts speak with ODD about future innovation in sustainable inhalation drug delivery
Kindeva scientists talk to BBC Witness History about the world's first modern asthma inhaler
Kindeva experts talk to PMPS about the lasting impact COVID-19 will have on drug delivery
Show, don't tell: how CDMO quality systems affect your product
Biotech's mirrored universe: predictive engineering and digital twinning
Addressing the challenges of vaccines and intradermal delivery
Kindeva: A historic CDMO, reborn
Kindeva talks to the Star Tribune about its launch as an independent company
